RT Journal Article
SR Electronic
T1 Assessing cancer clinical trials: Will your patient benefit from a ‘breakthrough’?
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP 368
OP 376
VO 69
IS 5
A2 Maurie Markman
YR 2002
UL http://www.ccjm.org/content/69/5/368.abstract
AB Cancer patients and their families often ask their primary care physicians if a new treatment reported in the news can help them. Physicians familiar with the long and complicated process of oncologic clinical trials are in the best position to assess the potential for clinical benefit from a new antineoplastic therapy.